newsfilter
← Latest News
Business Wire·

Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial

Third Patient Enrolled in Deltacel-01 Completes Treatment Kiromic BioPharma, Inc. (OTCQB:KRBP) ("Kiromic" or the "Company") announces that Virginia Oncology Associates, PC (Norfolk, Virginia) has been activated as the